Menitorix

Manufactured by GlaxoSmithKline

Menitorix is a laboratory equipment product designed for the measurement and analysis of various biological and chemical samples. It is a versatile instrument that can be used in a wide range of research and testing applications.

Automatically generated - may contain errors

Lab products found in correlation

Priorix, by GlaxoSmithKline (1 mentions) Infanrix hexa, by GlaxoSmithKline (1 mentions) Rotateq, by Merck Group (1 mentions)

2 protocols using menitorix

Routine Infant Immunization Schedule

Check if the same lab product or an alternative is used in the 5 most similar protocols

All infants received routine immunisations according to the Australian National Immunisation Program: at birth: intramuscular HepB vaccine (H-B-Vax II Paediatric® (bioCSL)); at 6 weeks, 4 and 6 months of age: intramuscular combined diphtheria-tetanus-acellular pertussis (DTPa)-HepB-inactivated polio (IPV)-Haemophilus influenzae type b (Hib) vaccine (Infanrix® hexa (GlaxoSmithKline)), intramuscular 13-valent conjugate pneumococcal vaccine (PCV13) (conjugated to CRM197, a diphtheria toxin) (Prevenar13® (Wyeth)), and oral rotavirus vaccine (RotaTeq® (Merck)); at 12 months of age: subcutaneous measles-mumps-rubella (MMR) vaccine (Priorix® (GlaxoSmithKline)) or (M-M-R®II (Seqirus)) and intramuscular combined Hib and meningococcal C vaccine (conjugated to tetanus toxin) (Menitorix® (GlaxoSmithKline)). Approximately half of the infants were randomised to receive intradermal BCG-Denmark (Statens Serum Institute, Copenhagen) shortly after birth as part of the MIS BAIR. None of the infants received an influenza vaccine. Vaccine records were obtained from the National Australian Immunisation register and/or individual immunisation records.

Zimmermann P., Perrett K.P., Messina N.L., Donath S., Ritz N., van der Klis F.R, & Curtis N. (2019). The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses. EClinicalMedicine, 13, 21-30.

+ Open protocol

+ Expand

Hib-MenC Vaccine Antibody Response

Check if the same lab product or an alternative is used in the 5 most similar protocols

Antibody responses specific for Hib were studied as part of a single center, open-label clinical study in healthy adults aged 18-65 years, undertaken to generate a Hib reference serum for the UK’s National Institute for Biological Standards and Control (NIBSC). Written informed consent was obtained from the participants before enrollment. Ethical approval was obtained from the Oxfordshire Research Ethics Committee (OXREC Reference: 08/H0605/74). Volunteers received a Hib-MenC polysaccharide-protein conjugate vaccine (Menitorix®, GlaxoSmithKline), containing Hib polyribosyl ribitol phosphate (PRP, 5 μg) polysaccharide and meningococcal serogroup C polysaccharide (5 μg) individually conjugated to tetanus toxoid carrier protein (total 17.5 μg). Blood was taken from participants immediately prior to vaccination, and at 7 and 28 days after vaccination.

Trück J., Ramasamy M.N., Galson J.D., Rance R., Parkhill J., Lunter G., Pollard A.J, & Kelly D.F. (2014). Identification of antigen-specific B cell receptor sequences using public repertoire analysis. Journal of immunology (Baltimore, Md. : 1950), 194(1), 252-261.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!